Praxis Precision Medicines, Inc. 8-K

What Happened

• On May 7, 2026, Praxis Precision Medicines, Inc. announced its financial results for the quarter ended March 31, 2026 via a press release; that press release is furnished as Exhibit 99.1 to the Form 8-K. On the same date the company updated its corporate presentation for investor and analyst meetings and posted it on its investor website; the presentation is furnished as Exhibit 99.2.

Key Details

• Date of announcements: May 7, 2026.
• Quarter covered: quarter ended March 31, 2026 (Q1 2026).
• Exhibits furnished with the Form 8-K: Exhibit 99.1 (press release) and Exhibit 99.2 (May 2026 corporate presentation).
• The company states the information in Items 2.02 and 7.01 (including Exhibits 99.1 and 99.2) is furnished, not filed, and is not subject to Section 18 liability or automatically incorporated by reference into other filings.

Why It Matters

• This filing provides investors with Praxis’s latest quarterly results and an updated investor presentation — primary sources for current earnings and operational context. Retail investors should review the press release and the corporate presentation on the company's Investors + Media website for the detailed quarterly results, cash position, and any management commentary included in those materials.